previous | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00768 | 1 | SACOL0470 | 57285497 | superantigen-like protein | 352 | Virulence Associated Factor | March 2008 | 2RDG | 24.4% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00769 | 1 | SACOL0472 | 57285499 | superantigen-like protein | 308 | Virulence Associated Factor | March 2008 | 2RDG | 26.3% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00770 | 1 | SACOL0473 | 57285500 | superantigen-like protein | 232 | Virulence Associated Factor | March 2008 | 2QEJ | 47% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00771 | 1 | SACOL0474 | 57285501 | superantigen-like protein | 227 | Virulence Associated Factor | March 2008 | 2QEJ | 35.2% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00772 | 1 | SACOL0478 | 57285505 | superantigen-like protein | 225 | Virulence Associated Factor | March 2008 | 2RDG | 59.6% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00706 | 1 | SACOL0504 | 57285529 | ABC transporter, ATP-binding protein | 341 | Conserved Gene / Pathway | March 2008 | 3DHW | 46% | Staphylococcus aureus | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP00844 | 1 | SACOL0519 | 57285544 | acetyltransferase, GNAT family | 174 | Drug Target Function | March 2008 | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||||
| IDP00600 | 1 | SACOL0532 | 57285557 | hypothetical protein SACOL0532 | 51 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00655 | 1 | SACOL0536 | 57285561 | ksgA | dimethyladenosine transferase | 297 | Conserved Gene / Pathway | March 2008 | 1QYR | 31.6% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00656 | 1 | SACOL0543 | 57284226 | glmU | UDP-N-acetylglucosamine pyrophosphorylas... | 450 | Drug Target Function | March 2008 | 1G95 | 49.1% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00627 | 1 | SACOL0552 | 57285570 | hypothetical protein SACOL0552 | 133 | Conserved Gene / Pathway | March 2008 | 1SRO | 31.6% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00773 | 1 | SACOL0569 | 57285587 | ATP:guanido phosphotransferase | 335 | Drug Target Function | March 2008 | 1QK1 | 21.8% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00612 | 1 | SACOL0582 | 57285598 | nusG | transcription antitermination protein Nu... | 182 | Drug Target Function | March 2008 | 2JVV | 40.7% | Staphylococcus aureus | Transcription | Transcription factors | |||||||||||||||||
| IDP00774 | 1 | SACOL0597 | 57285613 | chaperone protein HchA | 292 | Drug Target Function | March 2008 | 1IZY | 54.1% | Staphylococcus aureus | Hypothetical proteins | Conserved | ||||||||||||||||||
| IDP00775 | 1 | SACOL0611 | 57285626 | glycosyl transferase, group 1 family pro... | 490 | Conserved Gene / Pathway | March 2008 | 2JJM | 14.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00776 | 1 | SACOL0612 | 57285627 | glycosyl transferase, group 1 family pro... | 496 | Conserved Gene / Pathway | March 2008 | 2JJM | 11.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00777 | 1 | SACOL0665 | 57284261 | iron compound ABC transporter, iron comp... | 295 | Conserved Gene / Pathway | March 2008 | 1N2Z | 23.7% | Staphylococcus aureus | Cell envelope | Other | ||||||||||||||||||
| IDP00778 | 1 | SACOL0668 | 57284264 | hydrolase, alpha/beta hydrolase fold fam... | 266 | Drug Target Function | March 2008 | 1VA4 | 27.4% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00609 | 1 | SACOL0690 | 57285660 | ABC transporter, ATP-binding protein | 247 | Conserved Gene / Pathway | March 2008 | 3D31 | 29.1% | Staphylococcus aureus | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP00779 | 1 | SACOL0691 | 57285661 | sirR | iron-dependent repressor | 214 | Conserved Gene / Pathway | March 2008 | 1FX7 | 27.1% | Staphylococcus aureus | Regulatory functions | DNA interactions | |||||||||||||||||
| IDP00780 | 1 | SACOL0694 | 57285664 | tagH protein, teichoic acid ABC transpor... | 264 | Conserved Gene / Pathway | March 2008 | 1VPL | 23.9% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00707 | 1 | SACOL0704 | 57285674 | iron compound ABC transporter, ATP-bindi... | 265 | Conserved Gene / Pathway | March 2008 | 2OLJ | 30.6% | Staphylococcus aureus | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP00603 | 1 | SACOL0726 | 57285695 | sarX | staphylococcal accessory protein X | 141 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||||
| IDP00657 | 1 | SACOL0761 | 57285726 | nagA | N-acetylglucosamine-6-phosphate deacetyl... | 393 | Drug Target Function | March 2008 | 2VHL | 46.3% | Staphylococcus aureus | Central intermediary metabolism | Amino sugars | |||||||||||||||||
| IDP00708 | 1 | SACOL0779 | 57285742 | ABC transporter, ATP-binding protein | 625 | Conserved Gene / Pathway | March 2008 | 2IW3 | 22.2% | Staphylococcus aureus | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP00709 | 1 | SACOL0798 | 57285759 | iron compound ABC transporter, ATP-bindi... | 253 | Conserved Gene / Pathway | March 2008 | 1F3O | 31.6% | Staphylococcus aureus | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP00658 | 1 | SACOL0801 | 57285762 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 307 | Drug Target Function | March 2008 | 1HSK | 99.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00659 | 1 | SACOL0806 | 57285767 | pepT | peptidase T | 408 | Drug Target Function | March 2008 | 1VIX | 51.7% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00660 | 1 | SACOL0816 | 57284278 | secA | preprotein translocase subunit SecA | 843 | Drug Target Function | March 2008 | 1TF2 | 60.7% | Staphylococcus aureus | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||
| IDP00661 | 1 | SACOL0827 | 57284289 | acetyltransferase, putative | 161 | Drug Target Function | March 2008 | 1OCX | 30.4% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00838 | 1 | SACOL0833 | 57284295 | clpP | ATP-dependent Clp protease, proteolytic ... | 195 | Drug Target Function | March 2008 | 2ZL0 | 65.1% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00734 | 1 | SACOL0841 | 57284303 | pgm | phosphoglyceromutase | 505 | Drug Target Function | March 2008 | 1EJJ | 62.6% | Staphylococcus aureus | Energy metabolism | Glycolysis/gluconeogenesis | |||||||||||||||||
| IDP00781 | 1 | SACOL0845 | 57284307 | est | carboxylesterase | 246 | Conserved Gene / Pathway | March 2008 | 1R1D | 57.7% | Staphylococcus aureus | Cellular processes | Detoxification | |||||||||||||||||
| IDP00782 | 1 | SACOL0857 | 57284318 | staphylocoagulase precursor, putative | 508 | Conserved Gene / Pathway | March 2008 | 2A1D | 16.9% | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP00630 | 1 | SACOL0861 | 57284322 | cold shock protein, CSD family | 66 | Conserved Gene / Pathway | March 2008 | 2I5M | 71.2% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00841 | 1 | SACOL0876 | 57284336 | arsenate reductase, putative | 118 | Conserved Gene / Pathway | March 2008 | 1RW1 | 28% | Staphylococcus aureus | Cellular processes | Detoxification | ||||||||||||||||||
| IDP00783 | 1 | SACOL0885 | 57284344 | pathogenicity island protein, integrase ... | 406 | Conserved Gene / Pathway | March 2008 | 2A3V | 11.1% | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP00646 | 1 | SACOL0887 | 57284346 | sei | staphylococcal enterotoxin type I | 242 | Virulence Associated Factor | March 2008 | 2G9H | 55% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00601 | 1 | SACOL0893 | 57284352 | pathogenicity island protein | 48 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00784 | 1 | SACOL0896 | 57284355 | pathogenicity island protein | 289 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00786 | 1 | SACOL0899 | 57285775 | pathogenicity island protein | 94 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00602 | 1 | SACOL0903 | 57285779 | pathogenicity island protein | 72 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00785 | 1 | SACOL0904 | 57285780 | pathogenicity island protein | 175 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00620 | 1 | SACOL0937 | 57285812 | dltC | D-alanine--poly(phosphoribitol) ligase s... | 78 | Conserved Gene / Pathway | March 2008 | 1DV5 | 41% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00662 | 1 | SACOL0945 | 57285819 | cytosol aminopeptidase | 491 | Drug Target Function | March 2008 | 1GYT | 31.4% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00735 | 1 | SACOL0959 | 57285833 | NADH-dependent flavin oxidoreductase, Oy... | 375 | Drug Target Function | March 2008 | 1VJI | 29.3% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00736 | 1 | SACOL0966 | 57285840 | pgi | glucose-6-phosphate isomerase | 443 | Drug Target Function | March 2008 | 1B0Z | 63.2% | Staphylococcus aureus | Energy metabolism | Glycolysis/gluconeogenesis | |||||||||||||||||
| IDP00845 | 1 | SACOL0968 | 57285842 | spsA | signal peptidase IA, inactive | 174 | Drug Target Function | March 2008 | Staphylococcus aureus | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||||
| IDP00710 | 1 | SACOL0969 | 57285843 | spsB | signal peptidase IB | 194 | Drug Target Function | March 2008 | Staphylococcus aureus | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||||
| IDP00663 | 1 | SACOL0979 | 57285852 | clpB | ATP-dependent Clp protease, ATP-binding ... | 869 | Drug Target Function | March 2008 | 1QVR | 54.3% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00737 | 1 | SACOL0993 | 57284367 | oppD | oligopeptide ABC transporter, ATP-bindin... | 360 | Drug Target Function | March 2008 | 1B0U | 25% | Staphylococcus aureus | Transport and binding proteins | Amino acids, peptides and amines | |||||||||||||||||
| IDP00738 | 1 | SACOL0994 | 57284368 | oppF | oligopeptide ABC transporter, ATP-bindin... | 313 | Drug Target Function | March 2008 | 2YZ2 | 27.2% | Staphylococcus aureus | Transport and binding proteins | Amino acids, peptides and amines | |||||||||||||||||
| IDP00711 | 1 | SACOL0997 | 57284371 | oligopeptide ABC transporter, ATP-bindin... | 328 | Conserved Gene / Pathway | March 2008 | 3DHW | 26.2% | Staphylococcus aureus | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP00712 | 1 | SACOL0998 | 57284372 | oligopeptide ABC transporter, ATP-bindin... | 326 | Conserved Gene / Pathway | March 2008 | 3DHW | 29.1% | Staphylococcus aureus | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP00787 | 1 | SACOL1016 | 57284388 | fabI | enoyl-(acyl carrier protein) reductase | 256 | Drug Target Function | March 2008 | 2QIO | 62.5% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00664 | 1 | SACOL1028 | 57284400 | htrA | serine protease | 769 | Drug Target Function | March 2008 | 2ZLE | 12.7% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00788 | 1 | SACOL1043 | 57284414 | glycosyl transferase, group 1 family pro... | 493 | Conserved Gene / Pathway | March 2008 | 2JJM | 16.2% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00739 | 1 | SACOL1063 | 57284433 | acetyltransferase, GNAT family | 144 | Drug Target Function | March 2008 | 1Q2Y | 40.3% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00789 | 1 | SACOL1066 | 57284436 | fmt protein | 397 | Conserved Gene / Pathway | March 2008 | 2QMI | 16.1% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00665 | 1 | SACOL1079 | 57285865 | purF | amidophosphoribosyltransferase | 494 | Drug Target Function | March 2008 | 1AO0 | 51% | Staphylococcus aureus | Purines, pyrimidines, nucleosides, and nucleotides | Purine ribonucleotide biosynthesis | |||||||||||||||||
| IDP00666 | 1 | SACOL1096 | 57285882 | TrkA potassium uptake family protein | 220 | Drug Target Function | March 2008 | 2HMS | 36.4% | Staphylococcus aureus | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP00790 | 1 | SACOL1103 | 57285889 | pdhB | pyruvate dehydrogenase complex E1 compon... | 325 | Drug Target Function | March 2008 | 1W85 | 75.4% | Staphylococcus aureus | Energy metabolism | Pyruvate dehydrogenase | |||||||||||||||||
| IDP00740 | 1 | SACOL1105 | 57285891 | pdhD | dihydrolipoamide dehydrogenase | 468 | Drug Target Function | March 2008 | 1EBD | 70.9% | Staphylococcus aureus | Energy metabolism | Pyruvate dehydrogenase | |||||||||||||||||
| IDP00713 | 1 | SACOL1108 | 57285894 | spermidine/putrescine ABC transporter, A... | 364 | Conserved Gene / Pathway | March 2008 | 2D62 | 40.4% | Staphylococcus aureus | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP00636 | 1 | SACOL1118 | 57285904 | typA | GTP-binding protein TypA | 615 | Drug Target Function | March 2008 | 3E3X | 27.2% | Staphylococcus aureus | Unknown function | General | |||||||||||||||||
| IDP00667 | 1 | SACOL1134 | 57285920 | kdtB | lipopolysaccharide core biosynthesis pro... | 160 | Conserved Gene / Pathway | March 2008 | 1O6B | 56.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00615 | 1 | SACOL1160 | 57284445 | sdhB | succinate dehydrogenase iron-sulfur subu... | 271 | Conserved Gene / Pathway | March 2008 | 1E7P | 25.1% | Staphylococcus aureus | Energy metabolism | TCA cycle | |||||||||||||||||
| IDP00846 | 1 | SACOL1177 | 57284462 | hypothetical protein SACOL1177 | 43 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00791 | 1 | SACOL1178 | 57284463 | superantigen-like protein | 238 | Virulence Associated Factor | March 2008 | 1M4V | 23.9% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00792 | 1 | SACOL1179 | 57284464 | superantigen-like protein | 241 | Virulence Associated Factor | March 2008 | 1ET9 | 22.8% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00793 | 1 | SACOL1180 | 57284465 | superantigen-like protein | 241 | Virulence Associated Factor | March 2008 | 2R61 | 25.7% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00842 | 1 | SACOL1186 | 57284471 | antibacterial protein (phenol soluble mo... | 44 | Drug Target Function | March 2008 | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||||
| IDP00794 | 1 | SACOL1194 | 57284479 | pbp1 | penicillin-binding protein 1 | 744 | Drug Target Function | March 2008 | 1PYY | 30.9% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00668 | 1 | SACOL1196 | 57284481 | murD | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 449 | Conserved Gene / Pathway | March 2008 | 2JFF | 31.4% | ||||||||||||||||||||